Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 47, Issue 3, March 2022, Pages 167-231
 
MONOGRAPHS
 
  
 Avacincaptad pegol.
Complement C5 inhibitor, Treatment of geographic atrophy secondary to dry age-related macular degeneration, Treatment of Stargardt disease.
Ciulla, L.M., Hussain, R.M.
Drugs Fut 2022, 47(3): 167
Summary | Full Text: PDF 
 
  
  
 Bomedemstat tosylate.
Lysine-specific demethylase 1 inhibitor, Treatment of essential thrombocythemia, Treatment of polycythemia vera, Treatment of myelofibrosis.
Ribeiro, D.
Drugs Fut 2022, 47(3): 173
Summary | Full Text: PDF 
 
  
  
 Mobocertinib.
EGFR ex20ins-specific tyrosine kinase inhibitor, Treatment for non-small cell lung cancer.
Guo, M.Z., Marrone, K.A., Spira, A., Scott, S.C.
Drugs Fut 2022, 47(3): 181
Summary | Full Text: PDF 
 
  
  
 Relacorilant.
Glucocorticoid receptor antagonist, Treatment of Cushing syndrome, Treatment of prostate cancer, Treatment of ovarian cancer.
Rickmann, M.
Drugs Fut 2022, 47(3): 191
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the Move.
Fernandez Bertolin, L.
Drugs Fut 2022, 47(3): 201
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 American Association for the Study of Liver Disease (AASLD) – The Liver Meeting. Virtual – November 12-15, 2021.
Odland, J.
Drugs Fut 2022, 47(3): 215
Summary | Full Text: PDF 
 
  
  
 American Heart Association (AHA) Scientific Sessions – 2021 Annual Meeting. Virtual – November 13-15, 2021.
Diaz, N.
Drugs Fut 2022, 47(3): 219
Summary | Full Text: PDF 
 
  
  
 Society for Neuroscience – 50th Annual Meeting. Virtual – November 8-11, 2021.
Puig Vilanova, E., Sudha, P.
Drugs Fut 2022, 47(3): 225
Summary | Full Text: PDF 
 
  
  
 American Society of Tropical Medicine and Hygiene, 70th Annual Meeting. Virtual – November 17-21, 2021.
De Las Heras Prat, P.
Drugs Fut 2022, 47(3): 229
Summary | Full Text: PDF 
 
  
 
  



© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences